# EKLF Gene Expression in β-thalassemia

> **NCT06440603** · — · NOT_YET_RECRUITING · sponsor: **Rofaida Hassan Ahmed** · enrollment: 150 (estimated)

## Conditions studied

- β-thalassemia

## Interventions

- **DIAGNOSTIC_TEST:** PCR

## Key facts

- **NCT ID:** NCT06440603
- **Lead sponsor:** Rofaida Hassan Ahmed
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07-01
- **Primary completion:** 2026-07-01
- **Final completion:** 2027-07-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06440603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06440603, "EKLF Gene Expression in β-thalassemia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06440603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*